Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.